Published in BMC Infect Dis on November 08, 2016
Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med (2011) 10.29
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol (2013) 7.81
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis (2006) 7.64
Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med (2010) 7.37
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis (2001) 6.92
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87
Clostridium difficile infection in Europe: a hospital-based survey. Lancet (2011) 6.25
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era. JAMA Intern Med (2015) 5.04
The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol (2011) 3.92
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88
Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis (2009) 3.86
Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol (2012) 3.59
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis (2013) 3.56
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect (2014) 3.33
Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis (2007) 3.21
Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol (2008) 2.17
Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med (2006) 2.17
Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis (1989) 2.08
Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis (2014) 2.00
Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med (2011) 1.98
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection. Clin Gastroenterol Hepatol (2009) 1.78
The emergence of 'hypervirulence' in Clostridium difficile. Int J Med Microbiol (2010) 1.58
Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol (2012) 1.46
Does confounding explain the association between PPIs and Clostridium difficile-related diarrhea? Am J Gastroenterol (2013) 1.32
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clin Microbiol Infect (2014) 1.24
Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One (2012) 1.08
Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency. Eur J Clin Microbiol Infect Dis (2011) 1.01
Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation. Am J Gastroenterol (2013) 1.00
Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect (2010) 0.97
Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011. BMC Infect Dis (2013) 0.95
Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. J Hosp Infect (2014) 0.92
Clostridium difficile 027 infection in Central Italy. BMC Infect Dis (2012) 0.86
Deaths involving Clostridium difficle: England and Wales, 1999 and 2001-06. Health Stat Q (2008) 0.84
Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital. J Prev Med Hyg (2009) 0.83
National European guidelines for the prevention of Clostridium difficile infection: a systematic qualitative review. J Hosp Infect (2014) 0.83
Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study. Clin Microbiol Infect (2014) 0.82
[Increases in Clostridium difficile-related mortality rates in Spain (1999-2006)]. Enferm Infecc Microbiol Clin (2009) 0.81
Epidemiology of Clostridium difficile-associated disease in internal medicine wards in northern Italy. Intern Emerg Med (2012) 0.81
Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013. Euro Surveill (2016) 0.77
Pain management in internal medicine and effects of a standardised educational intervention: the FADOI-DOMINO study. Int J Clin Pract (2014) 1.40
Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother (2011) 1.24
Detection of a genetic linkage between genes coding for resistance to tetracycline and erythromycin in Clostridium difficile. Microb Drug Resist (2007) 0.84
Diagnostic testing for Clostridium difficile in Italian microbiological laboratories. Anaerobe (2015) 0.81
The LMW surface-layer proteins of Clostridium difficile PCR ribotypes 027 and 001 share common immunogenic properties. J Med Microbiol (2011) 0.80
Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age. Biol Blood Marrow Transplant (2015) 0.77
Antibiotic resistance patterns and PCR-ribotyping of Clostridium difficile strains isolated from swine and dogs in Italy. Anaerobe (2014) 0.77
Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND study. Diabetes Res Clin Pract (2016) 0.76
Molecular characterization and antimicrobial susceptibility of Clostridium difficile isolated from rabbits raised for meat production. Vet Microbiol (2015) 0.76
Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type. Anaerobe (2016) 0.75
Misdiagnosis of vertebral fractures on local radiographic readings of the multicentre POINT (Prevalence of Osteoporosis in INTernal medicine) study. Bone (2017) 0.75